Cancer – AHEP0731: Treatment of Children with All Stages of Hepatoblastoma
Condition or Therapy:
Cancer and Blood Disorders
Study Number: AHEP0731
What is the goal of this study?
This study looks at the side effects of how well risk-based therapy works in treating patients with newly diagnosed liver cancer.
Who can join the study?
This study may be a good fit for children and young adults who:
- are up to 21 years old and
- are newly diagnosed with hepatoblastoma.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.